Hereditary skin diseases of hemidesmosomes

Journal of Dermatological Science

Volumn 20, Issue 2, 1999, Pages 103-121

  Jonkman, Marcel F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Basement membrane; Bullous; Epidermolysis bullosa; Integrins; Laminins; Pemphigoid

Indexed keywords

INTEGRIN; KERATIN; LAMININ; PLECTIN;

BASEMENT MEMBRANE; BLISTER; CELL ADHESION; CELL PROLIFERATION; CELL SPREADING; CONFERENCE PAPER; CYTOSKELETON; EPIDERMOLYSIS BULLOSA; GENE MUTATION; GENE TARGETING; GENODERMATOSIS; HEMIDESMOSOME; HUMAN; INTERMEDIATE FILAMENT; KNOCKOUT MOUSE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; DESMOSOMES; EPIDERMOLYSIS BULLOSA; HUMANS; MUTATION; PEMPHIGOID, BULLOUS; SKIN DISEASES, GENETIC;

EID: 0033050072     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(99)00017-1     Document Type: Conference Paper

References (191)

1. Borradori L., Sonnenberg A. Hemidesmosomes: roles in adhesion, signaling and human diseases. Curr Opin Cell Biol. 8:1996;647-656.
2. Jones J.C.R., Hopkinson S.B., Goldfinger L.E. Structure and assembly of hemidesmosomes. Bioessays. 20:1998;488-494.
3. Zillikens D. Acquired disease of hemidesmosomes. J Dermatol Sci. 20:1999;134-154.
4. Christiano A.M., Uitto J. Molecular complexity of the cutaneous basement membrane zone. Exp Dermatol. 5:1996;1-11.
5. Pulkkinen L., Uitto J. Hemidesmosomal variants of epidermolysis bullosa. Mutations in the α6β4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes. Exp Dermatol. 7:1998;46-64.
6. Bruckner-Tuderman L. Hereditary skin disease of anchoring fibrils. J Dermatol Sci. 20:1999;122-133.
7. Smith F.J.D., Jonkman M.F., Van Goor H., Colemann C., Covello S.P., Uitto J., McLean W.H.I. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum Mol Genet. 7:1998;1143-1148.
8. Covello S.P., Smith F.J.D., Sillevis Smitt J.H., Paller A.S., Munro C.S., Jonkman M.F., Uitto J., McLean W.H.I. Keratin 17 mutations cause either steatocytoma multiplex or pachynychia congenita type 2. Br J Dermatol. 139:1998;475-480.
9. Anton-Lamprecht I. The skin. Papadimitriou J.M., Henderson D.W., Spagnolo D.V. Ultrastructure of Non-Neoplastic Diseases. 1992;459-550 Churchill Livingstone, Edinburgh.
10. Coulombe P.A., Hutton M.E., Letai A., Hebert A., Paller A.S., Fuchs E. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell. 66:1991;1301-1311.
11. Lane E.B., Rugg E.L., Navsaria H., Leigh I.M., Heagerty A.H., Ishida-Yamamoto A., Eady R.A. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature. 356:1992;244-246.
12. Fuchs E., Cleveland D.W. A structural scaffolding of intermediate filaments in health and disease. Science. 279:1998;514-519.
13. Corden L.D., McLean W.H. Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol. 5:1996;297-307.
14. Fuchs E. The cytoskeleton and disease: genetic disorders of intermediate filaments. Annu Rev Genet. 30:1996;197-231.
15. Shemanko C.S., Mellerio J.E., Tidman M., Lane E.B., Eady R.A.J. Severe palmo-plantar hyperkeratosis in Dowling-Meara epidermolysis bullosa simplex caused by a mutation in the keratin 14 gene (KRT14). J Invest Dermatol. 111:1998;893-895.
16. Uttam J., Hutton E., Coulombe P.A., Anton-Lamprecht I., Yu Q.C., Gedde-Dahl T. Jr, Fine J.D., Fuchs E. The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc Natl Acad Sci USA. 93:1996;9079-9084.
17. Irvine A.D., McKenna K.E., Jenkinson H., Hughes A.E. A mutation in the V1 domain of keratin 5 causes epidermolysis bullosa simplex with mottled pigmentation. J Invest Dermatol. 108:1997;809-810.
18. Ishida-Yamamoto A., McGrath J.A., Chapman S.J., Leigh I.M., Lane E.B., Eady R.A. Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol. 97:1991;959-968.
19. Kitajima Y., Jokura Y., Yaoita H. Epidermolysis bullosa simplex, Dowling-Meara type. A report of two cases with different types of tonofilament clumping. Br J Dermatol. 128:1993;79-85.
20. Anton-Lamprecht I. Ultrastructural identification of basic abnormalities as clues to genetic disorders of the epidermis. J Invest Dermatol. 103:1994;6S-12S.
21. Stephens K., Zlotogorski A., Smith L., Ehrlich P., Wijsman E., Livingston R.J., Sybert V.P. Epidermolysis bullosa simplex: a keratin 5 mutation is a fully dominant allele in epidermal cytoskeleton function. Am J Hum Genet. 56:1995;577-585.
22. Hu Z.L., Smith L., Martins S., Bonifas J.M., Chen H., Epstein E.H. Jr Partial dominance of a keratin 14 mutation in epidermolysis bullosa simplex - increased severity of disease in a homozygote. J Invest Dermatol. 109:1997;360-364.
23. Chan Y., Anton-Lamprecht I., Yu Q., Jäckel A., Zabel B., Ernst J.P., Fuchs E. A human keratin 14 'knockout': the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev. 8:1994;2574-2587.
24. Rugg E.L., McLean W.H.I., Lane E.B., Pitera R., McMillan J.R., Dopping-Hepenstal P.J.C., Navsaria H.A., Leigh I.M., Eady R.A.J. A functional 'knockout' of human keratin 14. Genes Dev. 8:1994;2563-2573.
25. Jonkman M.F., Heeres K., Pas H.H., van Luyn M.J.A., Elema J.D., Corden L.D., Smith F.J.D., McLean W.H.I., Ramaekers F.C.S., Burton M., Scheffer H. Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. J Invest Dermatol. 107:1996;764-769.
26. Corden L.D., Mellerio J.E., Gratian M.J., Eady R.A., Harper J.I., Lacour M., Magee G., Lane E.B., McGrath J.A., McLean W.H. Homozygous nonsense mutation in helix 2 of K14 causes severe recessive epidermolysis bullosa simplex. Hum Mutat. 11:1998;279-285.
27. Furumura M., Imayama S., Hori Y. Three neonatal cases of epidermolysis bullosa herpetiformis (Dowling-Meara type) with severe erosive skin lesions. J Am Acad Dermatol. 28:1993;859-861.
28. Krous H.F. Lethal Dowling-Meara-type epidermolysis bullosa simplex in a young infant. Pediatr Pathol Lab Med. 15:1995;191-200.
29. Foisner R., Feldman B., Sander L., Wiche G. Monoclonal antibody mapping of structural and functional plectin epitopes. J Cell Biol. 112:1991;397-405.
30. Stanley J.R., Tanaka T., Mueller S., Klaus K.V., Roop D. Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest. 82:1988;1864-1870.
31. Skalli O., Jones J.C.R., Gagescu R., Goldman R.D. IFAP 300 is common to desmosomes and hemidesmosomes and is a possible linker of intermediate filaments to these junctions. J Cell Biol. 125:1994;159-170.
32. Kurpakus M.A., Jones J.C. A novel hemidesmosomal plaque component: tissue distribution and incorporation into assembling hemidesmosomes in an in vitro model. Exp Cell Res. 194:1991;139-146.
33. Baker S.E., Skalli O., Goldman R.D., Jones J.C. Laminin-5 and modulation of keratin cytoskeleton arrangement in FG pancreatic carcinoma cells: involvement of IFAP300 and evidence that laminin-5/cell interactions correlate with a dephosphorylation of α6A integrin. Cell Motil Cytoskeleton. 37:1997;271-286.
34. Ruhrberg C., Watt F.M. The plakin family: versatile organizers of cytoskeletal architecture. Curr Opin Genet Dev. 7:1997;392-397.
35. Wiche G., Becker B., Luber K., Weitzer G., Castanon M.J., Hauptmann R., Stratowa C., Stewart M. Cloning and sequencing of rat plectin indicates a 466-kD polypeptide chain with a three-domain structure based on a central α-helical coiled coil. J Cell Biol. 114:1991;83-99.
36. Andra K., Lassmann H., Bittner R., Shorny S., Fassler R., Propst F., Wiche G. Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev. 11:1997;3143-3156.
37. Foisner R., Wiche G. Intermediate filament-associated proteins. Curr Opin Cell Biol. 3:1991;75-81.
38. Herrmann H., Wiche G. Plectin and IFAP-300K are homologous proteins binding to microtubule-associated proteins 1 and 2 and to the 240-kilodalton subunit of spectrin. J Biol Chem. 262:1987;1320-1325.
39. Sanchez A.P., de Martinez V., Niessen C.M., Borradori L., Kuikman I., Hulsman E.H., Fassler R., Owaribe K., Sonnenberg A. The subcellular distribution of the high molecular mass protein, HD1, is determined by the cytoplasmic domain of the integrin β4 subunit. J Cell Sci. 110:1997;169-178.
40. Rezniczek G.A., de-Pereda J.M., Reipert S., Wiche G. Linking integrin α6β4-based cell adhesion to the intermediate filament cytoskeleton: direct interaction between the β4 subunit and plectin at multiple molecular sites. J Cell Biol. 141:1998;209-225.
41. Hieda Y., Nishizawa Y., Uematsu J., Owaribe K. Identification of a new hemidesmosomal protein, HD1: a major, high molecular mass component of isolated hemidesmosomes. J Cell Biol. 116:1992;1497-1506.
42. McLean W.H., Pulkkinen L., Smith F.J., Rugg E.L., Lane E.B., Bullrich F., Burgeson R.E., Amano S., Hudson D.L., Owaribe K., McGrath J.A., McMillan J.R., Eady R.A., Leigh I.M., Christiano A.M., Uitto J. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev. 10:1996;1724-1735.
43. Gache Y., Chavanas S., Lacour J.P., Wiche G., Owaribe K., Meneguzzi G., Ortonne J.P. Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest. 97:1996;2289-2298.
44. Smith F.J., Eady R.A., Leigh I.M., McMillan J.R., Rugg E.L., Kelsell D.P., Bryant S.P., Spurr N.K., Geddes J.F., Kirtschig G., Milana G., de-Bono A.G., Owaribe K., Wiche G., Pulkkinen L., Uitto J., McLean W.H., Lane E.B. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet. 13:1996;450-457.
45. Pulkkinen L., Smith F.J., Shimizu H., Murata S., Yaoita H., Hachisuka H., Nishikawa T., McLean W.H., Uitto J. Homozygous deletion mutations in the plectin gene (PLEC1) in patients with epidermolysis bullosa simplex associated with late-onset muscular dystrophy. Hum Mol Genet. 5:1996;1539-1546.
46. Chavanas S., Pulkkinen L., Gache Y., Smith F.J., McLean W.H., Uitto J., Ortonne J.P., Meneguzzi G. A homozygous nonsense mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest. 98:1996;2196-2200.
47. Mellerio J.E., Smith F.J., McMillan J.R., McLean W.H., McGrath J.A., Morrison G.A., Tierney P., Albert D.M., Wiche G., Leigh I.M., Geddes J.F., Lane E.B., Uitto J., Eady R.A. Recessive epidermolysis bullosa simplex associated with plectin mutations: infantile respiratory complications in two unrelated cases. Br J Dermatol. 137:1997;898-906.
48. Dang M., Pulkkinen L., Smith F.J., McLean W.H., Uitto J. Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular dystrophy and the use of protein truncation test for detection of premature termination codon mutations. Lab Invest. 78:1998;195-204.
49. McMillan J.R., McGrath J.A., Tidman M., Eady R.A.J. Hemidesmosomes show abnormal association with the keratin filament network in junctional forms of epidermolysis bullosa. J Invest Dermatol. 110:1998;132-137.
50. Uitto J., Pulkkinen L., Smith F.J., McLean W.H. Plectin and human genetic disorders of the skin and muscle. The paradigm of epidermolysis bullosa with muscular dystrophy. Exp Dermatol. 5:1996;237-246.
51. Foisner R., Feldman B., Sander L., Seifert G., Artlieb U., Wiche G. A panel of monoclonal antibodies to rat plectin: distinction by epitope mapping and immunoreactivity with different tissues and cell lines. Acta Histochem (Jena). 96:1994;421-438.
52. Koss-Harnes D., Jahnsen F.L., Wiche G., Soyland E., Brandtzaeg P., Gedde-Dahl T. Jr Plectin abnormality in epidermolysis bullosa simplex Ogna: non- responsiveness of basal keratinocytes to some anti-rat plectin antibodies. Exp Dermatol. 6:1997;41-48.
53. Olaisen B., Gedde-Dahl T. Jr GPT-epidermolysis bullosa simplex (EBS Ogna) linkage in man. Hum Hered. 23:1973;189-196.
54. Liu C.G., Maercker C., Castanon M.J., Hauptmann R., Wiche G. Human plectin: organization of the gene, sequence analysis, and chromosome localization (8q24). Proc Natl Acad Sci USA. 93:1996;4278-4283.
55. Green K.J., Virata M.L., Elgart G.W., Stanley J.R., Parry D.A.D. Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments. Int J Biol Macromol. 14:1992;145-153.
56. Guo L., Degenstein L., Dowling J., Yu Q.C., Wollmann R., Perman B., Fuchs E. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell. 81:1995;233-243.
57. Brown A., Bernier G., Mathieu M., Rossant J., Kothary R. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet. 10:1995;301-306.
58. Yang Y., Dowling J., Yu Q.C., Kouklis P., Cleveland D.W., Fuchs E. An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell. 86:1996;655-665.
59. Sonnenberg A., Calafat J., Janssen H., Daams H., Van der Raaij-Helner M.H., Falcioni R., Kennel S.J., Aplin J.D., Baker J., Loizidou M., Garrod D.R. Integrin α6β4 complex is located in hemidesmosomes, suggesting major role in epidermal cell-basement membrane adhesion. J Cell Biol. 113:1991;907-917.
60. Nishizawa Y., Uematsu J., Owaribe K. HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J Biochem (Tokyo). 113:1993;493-501.
61. Watt F.M., Hertle M.D. Keratinocyte integrins. Leigh I.M., Lane E.B., Watt F.M. The Keratinocyte Handbook. 1994;153-164 Cambridge University Press, Cambridge, MA.
62. Niessen C.M., Hogervorst F., De Melker A.A., Delwel G.O., Hulsman E.H.M., Kuikman I., Sonnenberg A. The α6β4 integrin is a receptor for both laminin and kalinin. Exp Cell Res. 211:1994;360-367.
63. Mainiero F., Pepe A., Wary K.K., Spinardi L., Mohammadi M., Schlessinger J., Giancotti F.G. Signal transduction by the α6β4 integrin: distinct β4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes. EMBO J. 14:1995;4470-4481.
64. Schaapveld R.Q., Borradori L., Geerts D., van Leusden M.R., Kuikman I., Nievers M.G., Niessen C.M., Steenbergen R.D., Snijders P.J., Sonnenberg A. Hemidesmosome formation is initiated by the β4 integrin subunit, requires complex formation of β4 and HD1/plectin, and involves a direct interaction between β4 and the bullous pemphigoid antigen 180. J Cell Biol. 142:1998;271-284.
65. Niessen C.M., Hulsman E.H., Oomen L.C., Kuikman I., Sonnenberg A. A minimal region on the integrin β4 subunit that is critical to its localization in hemidesmosomes regulates the distribution of HD1/plectin in COS-7 cells. J Cell Sci. 110:1997;1705-1716.
66. Niessen C.M., Hulsman E.H., Rots E.S., Sanchez A.P., Sonnenberg A. Integrin α6β4 forms a complex with the cytoskeletal protein HD1 and induces its redistribution in transfected COS-7 cells. Mol Biol Cell. 8:1997;555-566.
67. Aho S., Uitto J. Direct interaction between the intracellular domains of bullous pemphigoid antigen 2 (BP180) and β4 integrin, hemidesmosomal components of basal keratinocytes. Biochem Biophys Res Commun. 243:1998;694-699.
68. Borradori L., Koch P.J., Niessen C.M., Erkeland S., Van Leusden M.R., Sonnenberg A. The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the β4 integrin subunit. J Cell Biol. 136:1997;1333-1347.
69. Delwel G.O., Sonnenberg A. Laminin isoforms and their integrin receptors. Horton M.A. Adhesion Receptors as Therapeutic Targets. 1996;9-36 CRC Press, Boca Raton, FL.
70. Hertle M.D., Adams J.C., Watt F.M. Integrin expression during human epidermal development in vivo and in vitro. Development. 112:1991;193-206.
71. Phillips R.J., Aplin J.D., Lake B.D. Antigenic expression of integrin α6β4 in junctional epidermolysis bullosa. Histopathology. 24:1994;571-576.
72. Gil S.G., Brown T.A., Ryan M.C., Carter W.G. Junctional epidermolysis bullosis: defects in expression of epiligrin/nicein/kalinin and integrin β4 that inhibit hemidesmosome formation. J Invest Dermatol. 103:1994;31S-38S.
73. Shimizu H., Suzumori K., Hatta N., Nishikawa T. Absence of detectable α6 integrin in pyloric atresia-junctional epidermolysis bullosa syndrome. Arch Dermatol. 132:1996;919-925.
74. Vidal F., Aberdam D., Miquel C., Christiano A.M., Pulkkinen L., Uitto J., Ortonne J.P., Meneguzzi G. Integrin β4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet. 10:1995;229-234.
75. Takizawa Y., Shimizu H., Nishikawa T., Hatta N., Pulkkinen L., Uitto J. Novel ITGB4 mutations in a patient with junctional epidermolysis bullosa-pyloric atresia syndrome and altered basement membrane zone immunofluorescence for the α6β4 integrin. J Invest Dermatol. 108:1997;943-946.
76. Pulkkinen L., Kurtz K., Xu Y., Bruckner-Tuderman L., Uitto J. Genomic organization of the integrin β4 gene (ITGB4): a homozygous splice-site mutation in a patient with junctional epidermolysis bullosa associated with pyloric atresia. Lab Invest. 76:1997;823-833.
77. Pulkkinen L. Compound heterozygosity for missense (L156P) and nonsense (R554X) mutations in the β4 integrin gene (ITGB4) underlies mild, nonlethal phenotype of epidermolysis bullosa with pyloric atresia. Am J Pathol. 152:1998;935-941.
78. Pulkkinen L., Kim D.-U., Uitto J. Epidermolysis bullosa with pyloric atresia: novel mutations in the β4 integrin gene (ITGB4). Am J Pathol. 152:1998;157-166.
79. Pulkkinen L., Rouan F., Bruckner-Tuderman L., Wallerstein R., Garzon M., Brown T., Smith L., Carter W.G., Uitto J. Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense. Am J Hum Genet. 63:1998;1376-1387.
80. Ruzzi L., Gagnoux-Palacios L., Pinola M., Belli S., Meneguzzi G., D'Alessio M., Zambruno G. A homozygous mutation in the integrin α6 gene in junctional epidermolysis bullosa with pyloric atresia. J Clin Invest. 99:1997;2826-2831.
81. Pulkkinen L., Kimonis V.E., Xu Y., Spanou E.N., McLean W.H., Uitto J. Homozygous α6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet. 6:1997;669-674.
82. Hayashi A.H., Galliani C.A., Gillis D.A. Congenital pyloric atresia and junctional epidermolysis bullosa: a report of long-term survival and a review of the literature. J Pediatr Surg. 26:1991;1341-1345.
83. Lestringant G.G., Akel S.R., Qayed K.I. The pyloric atresia-junctional epidermolysis bullosa syndrome. Report of a case and review of the literature. Arch Dermatol. 128:1992;1083-1086.
84. Berger T.G., Detlefs R.L., Donatucci C.F. Junctional epidermolysis bullosa, pyloric atresia, and genitourinary disease. Pediatr Dermatol. 3:1986;130-134.
85. Rosenberg D., Dodat H., Cottin X., Cambazard F., Chappuis J.P., Salle B. [Involvement of the urinary tract in a syndrome of congenital epidermolysis bullosa and atresia of the pylorus] Atteinte du tractus urinaire au cours du syndrome epidermolyse bulleuse congenitale-atresie du pylore. Arch Fr Pediatr. 44:1987;867-870.
86. Leschot N.J., Treffers P.E., Becker B.M., van-Zanten S., de-Groot W.P., Verjaal M. Severe congenital skin defects in a newborn. Case report and relevance of several obstetrical parameters. Eur J Obstet Gynecol Reprod Biol. 10:1980;381-388.
87. Niessen C.M., van der Raaij-Helmer M.H., Hulsman E.H., van der Neut R., Jonkman M.F., Sonnenberg A. Deficiency of the integrin β4 subunit in junctional epidermolysis bullosa with pyloric atresia: consequences for hemidesmosome formation and adhesion properties. J Cell Sci. 109:1996;1695-1706.
88. Georges-Labouesse E., Messaddeq N., Yehia G., Cadalbert L., Dierich A., Le Meur M. Absence of integrin α6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet. 13:1996;370-373.
89. Van der Neut R., Krimpenfort P., Calafat J., Niessen C.M., Sonnenberg A. Epithelial detachment due to absence of hemidesmosomes in integrin β4 null mice. Nat Genet. 13:1996;366-369.
90. Dowling J., Yu Q.C., Fuchs E. β4 Integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol. 134:1996;559-572.
91. Murgia C., Blaikie P., Kim N., Dans M., Petrie H.T., Giancotti F.G. Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin β4 cytoplasmic domain. EMBO J. 17:1998;3940-3951.
92. Wary K.K., Mariotti A., Zurzolo C., Giancotti F.G. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell. 94:1998;625-634.
93. Mainiero F., Murgia C., Wary K.K., Curatola A.M., Pepe A., Blumemberg M., Westwick J.K., Der C.J., Giancotti F.G. The coupling of α6β4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J. 16:1997;2365-2375.
94. Wary K.K., Mainiero F., Isakoff S.J., Marcantonio E.E., Giancotti F.G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell. 87:1996;733-743.
95. Shaw L.M., Rabinovitz I., Wang H.H., Toker A., Mercurio A.M. Activation of phosphoinositide 3-OH kinase by the α6β4 integrin promotes carcinoma invasion. Cell. 91:1997;949-960.
96. DiPersio C.M., Hodivala D.K., Jaenisch R., Kreidberg J.A., Hynes R.O. α3β1 Integrin is required for normal development of the epidermal basement membrane. J Cell Biol. 137:1997;729-742.
97. Carter W.G., Kaur P., Gil S.G., Gahr P.J., Wayner E.A. Distinct functions for integrins α3β1 in focal contacts and α6β4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes. J Cell Biol. 111:1990;3141-3154.
98. Kikkawa Y., Sanzen N., Sekiguchi K. Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. Laminin-10/11 mediates cell adhesion through integrin α3β1. J Biol Chem. 273:1998;15854-15859.
99. Kreidberg J.A., Donovan M.J., Goldstein S.L., Rennke H., Shepherd K., Jones R.C., Jaenisch R. α3β1 integrin has a crucial role in kidney and lung organogenesis. Development. 122:1996;3537-3547.
100. DiPersio C.M., Hodivala D.K., Jaenisch R., Kreidberg J.A., Hynes R.O. α3β1 Integrin is required for normal development of the epidermal basement membrane. J Cell Biol. 137:1997;729-742.
101. Jonkman M.F., De Jong M.C.J.M., Heeres K., Steijlen P., Owaribe K., Küster W., Meurer M., Gedde-Dahl T. Jr, Sonnenberg A., Bruckner-Tuderman L. Generalized atrophic benign epidermolysis bullosa: either 180-kD bullous pemphigoid antigen (BP180) or laminin-5 is deficient. Arch Dermatol. 132:1996;145-150.
102. Pulkkinen L., Jonkman M.F., McGrath J.A., Paller A.S., Uitto J. LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levels. Lab Invest. 78:1998;859-867.
103. Fleischmajer R., Utani A., MacDonald E.D., Perlish J.S., Pan T.C., Chu M.L., Nomizu M., Ninomiya Y., Yamada Y. Initiation of skin basement membrane formation at the epidermo-dermal interface involves assembly of laminins through binding to cell membrane receptors. J Cell Sci. 111:1998;1929-1940.
104. Giudice G.J., Emery D.J., Diaz L.A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol. 99:1992;243-250.
105. Li K., Tamai K., Tan M.L., Uitto J. Cloning of type XVII collagen. J Biol Chem. 268:1993;8825-8834.
106. Gatalica B., Pulkkinen L., Li K., Kuokkanen K., Ryynanen M., McGrath J.A., Uitto J. Cloning of the human type XVII collagen (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa. Am J Hum Genet. 60:1997;352-365.
107. Pas H.H., Kloosterhuis A.J., Heeres K., Van der Meer J.B., Jonkman M.F. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120 kD keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol. 108:1997;423-429.
108. Hirako Y., Usukura J., Nishizawa Y., Owaribe K. Demonstration of the molecular shape of BP180, a 180-kDa bullous pemphigoid antigen and its potential for trimer formation. J Biol Chem. 271:1996;13739-13745.
109. Balding S., Diaz L.A., Giudice G.J. A recombinant form of the human BP180 ectodomain forms a collagen-like homotrimeric complex. Biochemistry. 36:1997;8821-8830.
110. Pas H.H., Kloosterhuis A.J., Nijenhuis M., De Jong M.C.J.M., Van der Meer J.B., Jonkman M.F. Temperature-dependent dissociation of trimeric BP180 and LAD-1 to their monomers. J Invest Dermatol. 112:1999;58-61.
111. Schäcke H., Schumann H., Hammami-Hauasli N., Raghunath M., Bruckner-Tuderman L. Two forms of collagen XVII in keratinocytes. J Biol Chem. 273:1998;25937-25943.
112. Bedane C., McMillan J.R., Balding S., Bernard P., Prost C., Bonnetblanc J.M., Diaz L.A., Eady R.A.J., Giudice G.J. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separatable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol. 108:1997;901-907.
113. Masunaga T., Shimizu H., Yee C., Borradori L., Lazarova Z., Nishikawa T., Yancey K.B. The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J Invest Dermatol. 109:1997;200-206.
114. Owaribe K., Kartenbeck J., Stumpp S., Magin T.M., Krieg T., Diaz L.A., Franke W.W. The hemidesmosomal plaque. I. Characterization of a major constituent protein as a differentiation marker for certain forms of epithelia. Differentiation. 45:1990;207-230.
115. Kondo J., Kusachi S., Ninomiya Y., Yoshioka H., Oohashi T., Doi M., Murkami T., Moritani H., Kumashiro H., Tsuji T. Expression of type XVII collagen α1 chain mRNA in the mouse heart. Jpn Heart J. 39:1998;211-220.
116. Hopkinson S.B., Baker S.E., Jones J.C. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and α6 integrin. J Cell Biol. 130:1995;117-125.
117. Niessen C.M., Van Raaij-Helmer L.M.H., Hulsman E.H.M., Van der Neut R., Jonkman M.F., Sonnenberg A. Deficiency of the integrin β4 subunit in junctional epidermolysis bullosa with pyloric atresia: consequences for hemidesmosome formation and adhesion properties. J Cell Sci. 109:1996;1695-1706.
118. Borradori L., Chavanas S., Schaapveld R.Q.J., Gagnoux-Palacios L., Calafat J., Meneguzzi G. Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion - reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes. Exp Cell Res. 239:1998;463-476.
119. Jonkman M.F., De Jong M.C.J.M., Heeres K., Pas H.H., Van der Meer J.B., Martinez de Velasco A.M., Niessen C.M., Sonnenberg A. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest. 95:1995;1345-1352.
120. Pohla-Gubo G., Lazarova Z., Giudice G.J., Liebert M., Grasegger A., Hintner H., Yancey K.B. Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa. Exp Dermatol. 4:1995;199-206.
121. McGrath J.A., Gatalica B., Christiano A.M., Owaribe K., McMillan J.R., Eady R.A.J., Uitto J. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet. 11:1995;83-86.
122. McGrath J.A., Gatalica B., Li K., Dunnill G.S., McMillan J.R., Christiano A.M., Eady R.A., Uitto J. Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol. 148:1996;1787-1796.
123. McGrath J.A., Darling T., Gatalica B., Pohla-Gubo G., Hintner H., Christiano A.M., Yancey K.B., Uitto J. A homozygous deletion mutation in the gene encoding the 180-kD bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol. 106:1996;771-774.
124. Jonkman M.F., Scheffer H., Stulp R.P., Pas H.H., Nijenhuis M., Heeres K., Owaribe K., Pulkkinen L., Uitto J. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell. 88:1997;543-551.
125. Scheffer H., Stulp R.P., Verlind E., Van der Meulen M., Bruckner-Tuderman L., Gedde-Dahl T. Jr, Temeerman G.J., Sonnenberg A., Buys C.H.C.M., Jonkman M.F. Implications of intragenic marker homozygosity and haplotype sharing in a rare autosomal recessive disorder: The example of the collagen type XVII (COL17A1) locus in generalized atrophic benign epidermolysis bullos (GABEB). Hum Genet. 100:1997;230-235.
126. Schumann H., Hammami-Hauasli N., Pulkkinen L., Mauviel A., Kuester W., Luethi U., Owaribe K., Uitto J., Bruckner-Tuderman L. Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa. Am J Hum Genet. 60:1997;1344-1353.
127. Chavanas S., Gache Y., Tadini G., Pulkkinen L., Uitto J., Ortonne J.P., Meneguzzi G. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa. J Invest Dermatol. 109:1997;74-78.
128. Darling T.N., McGrath J.A., Yee C., Gatalica B., Hametner R., Bauer J.W., Pohla-Gubo G., Christiano A.M., Uitto J., Hintner H., Yancey K.B. Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol. 108:1997;463-468.
129. Mellerio J.E., Denyer J.E., Atherton D.J., Eady R.A., McGrath J.A. Prognostic implications of determining 180 kDa bullous pemphigoid antigen (BPAG2) gene/protein pathology in neonatal junctional epidermolysis bullosa. Br J Dermatol. 138:1998;661-666.
130. Darling T.N., Koh B.B., Bale S.J., Compton J.G., Bauer J.W., Hintner H., Yancey K.B. A deletion mutation in COL17A1 in five Austrian families with generalized atrophic benign epidermolysis bullosa represents propagation of an ancestral allele. J Invest Dermatol. 110:1998;170-173.
131. Darling T.N., Yee C., Koh B., McGrath J.A., Bauer J.W., Uitto J., Hintner H., Yancey K.B. Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol. 110:1998;165-169.
132. Floeth M., Fiedowowicz J., Schäcke H., Hammami-Hauasli N., Owaribe K., Trüeb R.M., Bruckner-Tuderman L. Novel homozygous and compound heterozygous COL17A1 mutations associated with junctional epidermolysis bullosa. J Invest Dermatol. 111:1998;528-533.
133. Shimizu H., Takizawa Y., Pulkkinen L., Zone J.J., Matsumoto K., Uitto J., Nishikawa T. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1. J Invest Dermatol. 111:1998;887-892.
134. Hashimoto I., Schnyder U.W., Anton-Lamprecht I. Epidermolysis bullosa hereditaria with junctional blistering in an adult. Dermatologica. 152:1976;72-86.
135. Schnyder U.W., Anton-Lamprecht I. Clinical aspects of epidermolyses with junctional blister formation (author's translation)] Zur Klinik der Epidermolysen mit junktionaler Blasenbildung. Dermatologica. 159:1979;402-406.
136. Hintner H., Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol. 118:1982;375-384.
137. Gedde-Dahl T. Jr, Anton-Lamprecht I. Epidermolysis bullosa. Emery A.E.H., Rimoin D.L. Principles and Practice of Medical Genetics. 1983;672-687 Churchill Livingstone, Edinburgh.
138. Kero M., Palotie A., Peltonen L. Collagen metabolism in two rare forms of epidermolysis bullosa. Br J Dermatol. 110:1984;177-184.
139. Heagerty A.H., Tidman M.J., Bor S., Eady R.A. Non-lethal junctional epidermolysis bullosa in two adult sisters. J R Soc Med. 78(Suppl 11):1985;32-33.
140. Zortea-Caflisch C. Epidermolysis bullosa atrophicans generalisata mitis. Hautarzt. 36:1985;176-178.
141. Paller A.S., Fine J.D., Kaplan S., Pearson R.W. The generalized atrophic benign form of junctional epidermolysis bullosa. Experience with four patients in the United States [published erratum appears in Arch Dermatol 1986;122(11):1297]. Arch Dermatol. 122:1986;704-710.
142. Hacham-Zadeh S. Benign junctional epidermolysis bullosa in three related Moroccan families [letter]. J Am Acad Dermatol. 14:1986;508-509.
143. Foldes C., Wallach D., Aubiniere E., Vignon-Pennamen M.D., Cottenot F. Generalized atrophic benign form of junctional epidermolysis bullosa. Dermatologica. 176:1988;83-90.
144. Prigent F., Blanchet-Bardon C., Mariano A., Chevallier B., Garabedian E.N., Bouderda Z., Lagardere B. [Non-fatal junctional epidermolysis bullosa (generalized, atrophic and benign)] Epidermolyse bulleuse jonctionnelle non letale (generalisee, atrophique et 'benigne'). Ann Dermatol Venereol. 116:1989;786-788.
145. Darling T.N., Bauer J.W., Hintner H., Yancey K.B. Generalized atrophic benign epidermolysis bullosa. Adv Dermatol. 13:1997;87-119.
146. Ichiki M., Kasada M., Hachisuka H., Sasai Y. Junctional epidermolysis bullosa with urethral stricture. Dermatologica. 175:1987;244-248.
147. Yamada Y., Dekio S., Jidoi J., Ishimoto T., Yoshioka T. Epidermolysis bullosa atrophicans generalisata mitis - report of a case with renal dysfunction. J Dermatol. 17:1990;690-695.
148. Chavanas S., Gache Y., Tadini G., Pulkkinen L., Uitto J., Ortonne J.P., Meneguzzi G. A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa. J Invest Dermatol. 109:1997;74-78.
149. Mazzanti C., Gobello T., Posteraro P., Paradisi M., Meneguzzi G., Chinni L., Zambruno G. 180-kDa bullous pemphigoid antigen defective generalized atrophic benign epidermolysis bullosa: report of four cases with an unusually mild phenotype. Br J Dermatol. 138:1998;859-866.
150. Tidman M., Eady R.A.J. Ultrastructural morphometry of normal human dermal-epidermal junction. The influence of age, sex, and body region on laminar and nonlaminar components. J Invest Dermatol. 83:1984;448-453.
151. Eady R.A. The basement membrane. Interface between the epithelium and the dermis: structural features. Arch Dermatol. 124:1988;709-712.
152. Goldberg M., Escaig-Haye F. Is the lamina lucida of the basement membrane a fixation artefact? Eur J Cell Biol. 42:1986;365-368.
153. Tidman M.J., Eady R.A.J. Hemidesmosome heterogeneity in junctional epidermolysis bullosa revealed by morphometric analysis. J Invest Dermatol. 86:1986;51-56.
154. Rouselle P., Lunstrum G.P., Keene D.R., Burgeson R.E. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol. 114:1991;567-576.
155. Fine J.D., Horiguchi Y., Couchman J.R. 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa. Arch Dermatol. 125:1989;520-523.
156. Marinkovich M.P., Taylor T.B., Keene D.R., Burgeson R.E., Zone J.J. LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. J Invest Dermatol. 106:1996;734-738.
157. Ishiko A., Shimizu H., Masunaga T., Hashimoto T., Dmochowski M., Wojnarowska F., Bhogal B.S., Black M.M., Nishikawa T. 97-kDa Linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane. J Invest Dermatol. 106:1996;739-743.
158. Motoki K., Megahed M., LaForgia S., Uitto J. Cloning and chromosomal mapping of mouse ladinin, a novel basement membrane zone component. Genomics. 39:1997;323-330.
159. Masunaga T., Shimizu H., Ishiko A., Tomita Y., Aberdam D., Ortonne J.P., Nishikawa T. Localization of laminin-5 in the epidermal basement membrane. J Histochem Cytochem. 44:1996;1223-1230.
160. Paulsson M. Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol. 27:1992;93-127.
161. Fine J.D. 19-DEJ-1, a monoclonal antibody to the hemidesmosome-anchoring filament complex, is the only reliable immunohistochemical probe for all major forms of junctional epidermolysis bullosa. Arch Dermatol. 126:1990;1187-1190.
162. Fine J.D., Johnson L.B., Wright T. Type VII collagen and 19-DEJ-1 antigen. Comparison of expression in inversa and generalized variants of recessive dystrophic epidermolysis bullosa. Arch Dermatol. 126:1990;1587-1593.
163. Jonkman M.F., Pas H.H., Fine J.D. Mosaic expression of uncein, linear IgA bullous dermatosis antigen and 180-kD bullous pemphigoid antigen in generalized atrophic benign epidermolysis bullosa [letter]. Br J Dermatol. 138:1998;904.
164. Chan L.S., Fine J.D., Briggaman R.A., Woodley D.T., Hammerberg C., Drugge R.J., Cooper K.D. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. J Invest Dermatol. 101:1993;262-267.
165. Chan L.S., Fine J.D., Hammerberg C., Bauer E.A., Cooper K.D. Defective in vivo expression and apparently normal in vitro expression of a newly identified 105-kDa lower lamina lucida protein in dystrophic epidermolysis bullosa. Br J Dermatol. 132:1995;725-729.
166. Zillikens D., Kawahara Y., Ishiko A., Shimizu H., Mayer J., Rank C.V., Liu Z., Giudice G.J., Tran H.H., Marinkovich M.P., Bröcker E.B., Hashimoto T. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol. 106:1996;1333-1338.
167. Zone J.J., Taylor T.B., Meyer L.J., Petersen M.J. The 97 kDa linear IgA bullous disease antigen is identical to a proportion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol. 110:1998;207-210.
168. Hirako Y., Usukura J., Uematsu J., Hashimoto T., Kitajima Y., Owaribe K. Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide. J Biol Chem. 273:1998;9711-9717.
169. Marinkovich M.P., Tran H.H., Rao S.K., Giudice G.J., Balding S., Jonkman M.F., Pas H.H., McGuire J.S., Scott Herron G., Bruckner-Tuderman L. LAD-1 is absent in a subset of junctional epidermolysis bullosa patients. J Invest Dermatol. 109:1997;356-359.
170. Burgeson R.E., Chiquet M., Deutzmanm R., Ekblom P., Engel J., Kleinman H., Martin G.R., Meneguzzi G., Paulsson M., Sanes J., Timpl R., Tryggvason K., Yamada Y., Yurchenco P.D. A new nomenclature for the laminins. Matrix Biol. 14:1994;209-211.
171. Burgeson R.E., Christiano A.M. The dermal-epidermal junction. Curr Opin Cell Biol. 9:1997;651-658.
172. Ryan M.C., Christiano A.M., Engvall E., Wewer U.M., Miner J.H., Sanes J.R., Burgeson R.E. The functions of laminins: lessons from in vivo studies. Matrix Biol. 15:1996;369-381.
173. Rouselle P., Keene D.R., Ruggiero F., Champliaud M.F., Van der Rest M., Burgeson R.E. Laminin-5 binds the NC-1 domain of type VII collagen. J Cell Biol. 138:1997;719-728.
174. Matsui C., Wang C.K., Nelson C.F., Bauer E.A., Hoeffler W.K. The assembly of laminin-5 subunits. J Biol Chem. 270:1995;23496-23503.
175. Cheng Y.S., Champliaud M.F., Burgeson R.E., Marinkovich M.P., Yurchenco P.D. Self-assembly of laminin isoforms. J Biol Chem. 272:1997;31525-31532.
176. Champliaud M.F., Lunstrum G.P., Rousselle P., Nishiyama T., Keene D.R., Burgeson R.E. Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. J Cell Biol. 132:1996;1189-1198.
177. Miner J.H., Patton B.L., Lentz S.I., Gilbert D.J., Snider W.D., Jenkins N.A., Copeland N.G., Sanes J.R. The laminin α-chains: expression, developmental transitions, and chromosomal locations of α1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel α3 isoform. J Cell Biol. 137:1997;685-701.
178. Kikkawa Y., Sanzen N., Sekiguchi K. Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. Laminin-10/11 mediates cell adhesion through integrin α3β1. J Biol Chem. 273:1998;15854-15859.
179. Heagerty A.H., Kennedy A.R., Eady R.A., Hsi B.L., Verrando P., Yeh C.J., Ortonne J.P. GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa [letter]. Lancet. 1:1986;860.
180. Verrando P., Blanchet-Bardon C., Pisani A., Thomas L., Cambazard F., Eady R.A., Schofield O., Ortonne J.P. Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest. 64:1991;85-92.
181. Baudoin C., Miquel C., Blanchet-Bardon C., Gambini C., Meneguzzi G., Ortonne J.P. Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression. J Clin Invest. 93:1994;862-869.
182. Vidal F., Baudoin C., Miquel C., Galliano M.F., Christiano A.M., Uitto J., Ortonne J.P., Meneguzzi G. Cloning of the laminin α3 chain gene (LAMA3) and identification of a homozygous deletion in a patient with Herlitz junctional epidermolysis bullosa. Genomics. 30:1995;273-280.
183. Pulkkinen L., Christiano A.M., Gerecke D., Wolfe Wagman D. A homozygous nonsense mutation in the β3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics. 24:1994;357-360.
184. Aberdam D., Galliano M.F., Vailly J., Pulkkinen L., Bonifas J., Christiano A.M., Tryggvason K., Uitto J., Epstein E.H. Jr, Ortonne J.P. et al. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the γ2 subunit of nicein/kalinin (LAMININ-5). Nat Genet. 6:1994;299-304.
185. Matsui C., Pereira P., Wang C.K., Nelson C.F., Kutzkey T., Lanigan C., Woodley D., Morohashi M., Welsh E.A., Hoeffler W.K. Extent of laminin-5 assembly and secretion effect junctional epidermolysis bullosa phenotype. J Exp Med. 187:1998;1273-1283.
186. McMillan J.R., McGrath J.A., Pulkkinen L., Kon A., Burgeson R.E., Ortonne J.P., Meneguzzi G., Uitto J., Eady R.A. Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation. Br J Dermatol. 136:1997;817-822.
187. McGrath J.A., Christiano A.M., Pulkkinen L., Eady R.A., Uitto J. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. J Invest Dermatol. 106:1996;1157-1159.
188. Cserhalmi-Friedman P.B., Baden H., Burgeson R.E., Christiano A.M. Molecular basis of non-lethal junctional epidermolysis bullosa: identification of a 38 basepair insertion and a splice site mutation in exon 14 of the LAMB3 gene. Exp Dermatol. 7:1998;105-111.
189. Pulkkinen L., Jonkman M.F., McGrath J.A., Kuijpers A., Paller A.S., Uitto J. LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levels. Lab Invest. 78:1998;859-867.
190. Pierce R.A., Griffin G.L., Mudd M.S., Moxley M.A., Longmore W.J., Sanes J.R., Miner J.H., Senior R.M. Expression of laminin α3, α4, and α5 chains by alveolar epithelial cells and fibroblasts. Am J Respir Cell Mol Biol. 19:1998;237-244.
191. Kuster J.E., Guarnieri M.H., Ault J.G., Flaherty IAP insertion in the murine LAMB3 gene results in junctional epidermolysis bullosa. Mamm Genome. 8:1997;673-681.